TABLE 3.

Predicted performance of baseline 25(OH)D for seropositivity of the anti-PLA2R Ab in patients with PMN.

Variables	Baseline 25(OH)D (nmol/L)		P-value
	≤20.05 (n = 279)	>20.05 (n = 211)
Patients with seropositivity of the anti-PLA2R Ab, no. (%)	201 (72.0%)	94 (44.5%)	<0.001
Unadjusted ORs	3.2 (2.2,4.7)	Reference	<0.001
Adjusted ORs, adjusted for
Model 1: age, gender and MBP	3.1 (2.1,4.5)	Reference	<0.001
Model 2: model 1 + 24 h urinary protein + eGFR	2.4 (1.6,3.7)	Reference	<0.001

Odds ratio (OR) and 95% confidence intervals were derived from logistic regression analyses. Model 1: unadjusted. Model 2: adjusted for age, gender, and MBP. Model 3: Model 2 plus 24-h urinary protein and eGFR. Anti-PLA2R Ab, anti-phospholipase A2 receptor antibody; MBP, mean blood pressure; eGFR, estimated glomerular filtration rate. A two-tailed P < 0.05 was considered statistically significant.